Skip to content

Gatekeeper European 005

Long Term Follow-up European Gatekeeper Study 005

Status
Terminated
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT00229086
Enrollment
55
Registered
2005-09-29
Start date
Unknown
Completion date
Unknown
Last updated
2008-07-28

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

GERD

Brief summary

Evaluation of the Gatekeeper System in the treatment of patients with Gastroesophageal Reflux Disease (GERD) who already have been treated under study protocols Endo 2000-03 and Endo 2000-04

Interventions

DEVICEGatekeeper Reflux Repari System (Device)

Sponsors

MedtronicNeuro
Lead SponsorINDUSTRY

Eligibility

Sex/Gender
ALL

Inclusion criteria

* Subjects must have been part of the Endo 2000-03 or Endo 2000-04 clinical study * Subjects who have been informed of the nature of the long-term follow-up study and have agreed to its participation and provided Informed Consent

Exclusion criteria

* Underwent another endoscopic or surgical treatment for GERD (except re-intervention with Gatekeeper) * Developed other medical illness that may cause the subject to be non-compliant * Extensive Barrett's Esophagus (\>2 cm) * Unable or unwilling to cooperate with the study procedures

Countries

Switzerland, United States

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026